Topotecan Completed Phase 2 Trials for Myelodysplastic Syndromes / Leukemias Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003675Topotecan in Treating Patients With Myelodysplastic Syndrome
NCT00003340Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
NCT00003255Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
NCT00003735Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
NCT00005962Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia